Directing the President, pursuant to section 5(c) of the War Powers Resolution, to remove United States Armed Forces from hostilities with Iran.

On April 27, 2026, Rep. Maxine Dexter (D-OR) introduced H. Con. Res. 91, a concurrent resolution invoking Section 5(c) of the War Powers Resolution to direct the President to remove U.S. Armed Forces from hostilities against Iran. The bill was referred to the House Committee on Foreign Affairs and remains in early stage. It is one of several identical or related resolutions (HCONRES87, 88, 89, 92) introduced around the same time, suggesting a coordinated messaging effort by multiple members rather than a singular legislative push. The bill's sponsor is a junior member of the majority party, not a committee chair or leadership figure, further reducing its legislative momentum. The money trail is zero. This bill authorizes no funding, appropriates no dollars, and creates no new program or contract. It is a purely procedural concurrent resolution expressing congressional opinion. Concurrent resolutions (H.Con.Res.) are not presented to the President and do not carry the force of law. Even if passed by both chambers, this resolution would not compel the President to act, as War Powers Resolution Section 5(c) is constitutionally contested and concurrent resolutions do not have legal binding effect on the executive branch. Structural winners and losers are absent. The bill does not create any new spending, regulatory standard, tax credit, or procurement mandate. Defense contractors continue on existing contracts unaffected. The Iran-related threat environment is a tailwind for certain defense programs (missile defense, strike aircraft, naval assets), but this resolution, even if passed, would not alter those programs. The existence of 13 related bills indicates political interest in the Iran war powers issue but zero progress toward any binding change in spending or policy. The bill's early-stage referral and lack of committee action suggest it will not move forward in the 119th Congress. The timeline for this bill is indefinite and likely dead. It has not been reported by committee, has no scheduled hearings, and faces a crowded legislative calendar in an election year. The companion identical bills further dilute its urgency, as they signal a diffuse coalition rather than a concentrated leadership push. Investors should ignore this bill for any market decisions.